Latest Resources

South Africa’s ban on GM import approvals

In September/October 2005, at the behest of the Department of Trade and Industry (DTI), the Executive Council (EC): GMO Act took the decision not to approve any more new GM applications for the purposes of importation in South Africa as food, feed and processing. The decision was taken to accommodate serious concerns by the DTI […]

Adenovirus type 5 with HIV gag, pol and nef genes / Chris Hani Baragwanath Hospital

Comments and Concerns on the application made by Prof. Glenda Gray in respect of HIV vaccine clinical trial of genetically modified organism (MRKAd5 HIV-1 gag/pol/nef) Comments and concerns It should be noted that this submission is written in the context of a country that is devastated by HIV-AIDS at every level. That solutions are needed […]

LibertyLink-Rice / Bayer CropScience

Application Made By Bayer Cropscience Gmbh In Respect Of A Commodity Clearance Application For Event Llrice62 To The National Department Of Agriculture, South Africa African Centre for Biosafety, supported by various organisations, groups, companies, and individuals. Read here.

Pharma Crops and GE Vaccines

HIV Vaccine Clinical Trial Of Genetically Modified Organism (MRKAd5 HIV1 gag/pol/nef) African Centre for Biosafety Jun 2006. Read here. The Status Of Genetically Modified (gm) Pharmaceutical Crop Research In South Africa Mar 2006 Rose Williams. Read here.

Bioethanol-Maize / Syngenta

COMMENTS BY THE AFRICAN CENTRE FOR BIOSAFETY AND THE CENTRE FOR FOOD SAFETY (USA) Comments on Syngenta’s Application for Commodity Clearance of Genetically Modified Maize, Event 3272 African Centre for Biosafety & Centre for Food Safety, 29 May 2006 Read here. OVERVIEW Syngenta’s Event 3272 maize represents the very first genetically modified (GM) industrial crop […]

Out of Africa: Mysteries of access and benefit sharing

In late 2005 the Edmunds Institute and the African Centre for Biosafety contacted famed bio-pirate hunter Jay McGowan to investigate incidences of access and benefit sharing in Africa. Despite many constraints on the research, McGowan found a plethora of incidents where transnational corporations had utilised African biodiversity without concluding benefit sharing agreements with the local […]

Bt-Maize 1507 x 59122 x NK 603 / Dow Agrosciences

SUBMISSION OF OBJECTIONS BY THE AFRICAN CENTRE FOR BIOSAFETY (ACB). OBJECTION TO APPLICATION BY DOW AGROSCIENCES TRIPLE STACKED GM MAIZE, EVENTS, 1507 x NK603 x 59199. Read objection here. OVERVIEW The African Centre for Biosafety (ACB) has to date, lodged objections to the following applications by Dow Agrosciences for commodity import clearance: – GM Maize […]

Roundup Ready Flex Cotton / Monsanto

SUBMISSION OF OBJECTIONS BY THE AFRICAN CENTRE FOR BIOSAFETY (ACB) OBJECTION TO MONSANTO’S APPLICATION FOR GENERAL RELEASE OF GM COTTON RR FLEX African Centre for Biosafety, Dec 2005 Read here. Summary The application is for a general release permit to allow the commercial sale and growing of a new transformation event MON88913, also known as […]

Bt-Maize MON89034 and MON89597 / Monsanto

SUBMISSION OF OBJECTIONS BY THE AFRICAN CENTRE FOR BIOSAFETY (ACB) Objections To The Application Made By Monsanto South Africa For A Permit For A Trial Release Of Mon89034 And Mon89597 African Centre for Biosafety, 01 Oct 2005 OVERVIEW DEVELOPER (MONSANTO) APPLICATION: AVAILABLE INFORMATION The dossier supplied by Monsanto is designated Non Confidential Business Information (Non-CBI). […]

Zambia – GMO Legislation

INTRODUCTION The Draft Labeling Standards are non-binding in the sense that they do not create legally binding obligations and responsibilities. As such, they are also not legally enforceable. The lack of teeth of the standards is not cured by the fact that the Zambian Bureau of Standards, a statutory body, produces the standards. However, the […]